All lobbying filings

KELLEY DRYE & WARREN LLP

Lobbying for TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Development of federal public policy and advocacy strategy and lobbying federal government

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $30,000.00 income · posted Apr 21, 2025

Official filing document

Bills named in this filing 3

HR 1510
Due Process Continuity of Care Act
HR 2483
SUPPORT for Patients and Communities Reauthorization Act of 2025
HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025

Lobbying activity 1

Health Issues

General issues relating to substance use prevention and treatment, including: Reentry Act (not yet introduced); Due Process and Continuity of Care Act (H.R. 1510); Modernizing Opioid Treatment Access Act (not yet introduced); the Support for Patients and Communities Reauthorization Act (H.R. 2483); and related provisions in FY25 continuing resolution (H.R. 1968)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.